We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fine-Tuning Stem Cell Therapy to Repair the Heart

By LabMedica International staff writers
Posted on 27 Mar 2013
Stem cells have the potential to grow into a range of cell types, including heart cells. More...
Researchers are now trying to refine the process of repairing and regenerating heart tissue damaged by a heart attack with stem cells.

A recent study from Cedars-Sinai Heart Institute (Los Angeles, CA, USA) suggests that stem cells may, undeniably, heal damaged hearts. The researchers treated 17 heart attack survivors with an infusion of stem cells taken from their own hearts. One year later, the amount of scar tissue had shrunk by about 50%. These findings look dramatic, but investigators are wondering if they an indication that they are close to perfecting stem cell therapy.

“This is a field where, depending on which investigator you ask, you can get incredibly different answers,” Dr. Richard Lee, professor of medicine at Harvard Medical School (Boston, MA, USA), and a leading specialist on stem cell therapy, reported in the March 2013 issue of Harvard Women’s Health Watch. “The field is young. Some studies show only modest or no improvement in heart function, but others have shown dramatically improved function. We’re waiting to see if other doctors can also achieve really good results in other patients.”

New research is generating contrary findings in part, because researchers use diverse approaches to harvest and use stem cells. Some are gathered from the bone marrow of donors, others from the recipient’s own heart. It is not evident which approach works optimally. “Some investigators think this is just a few years away,” concluded Dr. Lee. “And then there are others who feel that there is much more work to be done.”

Presently, stem cell therapy is available only to individuals who participate in a research trial.

Related Links:

Cedars-Sinai Heart Institute
Harvard Medical School




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.